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Summary
WHAT IS KNOWN ON THE SUBJECT, AND WHAT THE
STUDY ADDS: The number of home visits by general
practitioners (GPs) has decreased in recent years, in con-
trast to the increasing number of frail and older patients
in western countries. Current data on GP home visit num-
bers and rates are lacking for Switzerland. Our study pro-
vides new data on GP home visit numbers and rates, and
their associations with patient characteristics.
AIM: Our study aimed at investigating the time trend of GP
home visits to older patients from 2014 to 2018 in Switzer-
land, and associations between GP home visits and pa-
tient characteristics including healthcare utilisation and liv-
ing situation.
METHODS: Retrospective cross-sectional study of insur-
ance claims data from 2014 to 2018 among patients aged
≥65 years (Nextrapolated = 2,095,102; Nraw = 339,301). We
compared patient characteristics between patients with
and without GP home visits using descriptive statistics.
We performed logistic regression analyses to detect asso-
ciations between patient characteristics and GP home vis-
its, including subgroups of patients aged ≥80 and patients
living in a nursing home. Regression models were adjust-
ed for age and sex.
RESULTS: The yearly GP home visit rate declined from
10.7% to 9.3% from 2014 to 2018 (p <0.0001). Among pa-
tients aged ≥80, the rate declined from 26.1% to 23.1%
(p <0.0001), and among patients living in a nursing home
from 68.7% to 65.8% (p <0.0001). Regression analyses
revealed increased health care utilisation and a higher
burden of morbidity and mortality in patients receiving GP
home visits.
CONCLUSION: There is an ongoing decline of GP home
visits over the past years, with a potentially negative im-
pact on the quality of care for older and frail patients.
Introduction
Home visits by general practitioners (GPs) are an impor-
tant component of home care and highly valued by patients
in terms of care quality, continuity of care and trust [1, 2].
Demand for home visits by GPs is associated with sever-
al patient factors, such as higher age [3, 4], lower social
class [4], female sex [5], living in a rural area [6–8], the
number of comorbidities and frailty [5, 9, 10]. Because of
demographic changes, with increasing age, multimorbidi-
ty, frailty and impaired mobility of the population, we have
to face an increasing demand for home visits in the future
[11]. In contrast, the number of home visits by GPs has
continuously decreased in western countries during past
decades, for a variety of reasons at the GP level as well as
at the healthcare system level [1, 4, 12–15]. In Switzerland,
there are only few studies available, which showed a simi-
lar decline as in other western countries in the past decades
(until 2015) [14, 15]. To our knowledge, current data on
time trends in GP home visits representative for Switzer-
land, including the association with patient characteristics,
are lacking. Thus, the aim of our study was first to mea-
sure GP home visit rates for the years 2014 to 2018, in a
representative Swiss population at older age, and second
to investigate associations between GP home visits and pa-
tient characteristics, including healthcare utilisation mea-
sures, multimorbidity and living situation (at home or in a
nursing home).
Materials and methods
Study design and data source
We performed a retrospective cross-sectional study using
health insurance claims data from individuals with manda-
tory health insurance (1 January 2014 to 31 December
2018). The health insurance company involved (Helsana)
is one of the largest in Switzerland, covering 1.1 million
individuals from all geographic regions (cantons) (15%
of the Swiss population). The database comprises infor-
mation on individuals’ sociodemographics (age, sex, ge-
ographic region), inpatient and outpatient healthcare util-
isation including dispensed medications (including active
substances in the form of ATC [anatomical therapeutic
chemical] codes) and their corresponding costs. Addition-
ally, the database provides the type of practicing physician,
which allows services performed by GPs to be identified.
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We included in our analysis all patients aged 65 or older
who were continuously insured at Helsana in the given cal-
endar year. Persons who died or changed basic insurance
provider were excluded from the corresponding year. In or-
der to draw conclusions about the general population of
Switzerland, all descriptive statistics (including absolute
numbers of the population and subpopulations, rates,
means and standard deviations) were extrapolated to the
total Swiss population. Regression models were based on
the raw data.
Main objectives
1. To measure the time trend in GP home visit rates per
year. These rates were defined as the annual proportion
of patients with at least one GP home visit relative to
the total number of insured individuals aged 65 years
or older.
2. To explore the association between patient characteris-
tics and GP home visits (year 2018), defined as a bina-
ry coded variable indicating whether an individual had
received at least one GP home visit per year, per pa-
tient.
Patient characteristics
Sociodemographic characteristics of the patients included
age and sex. For the number of chronic conditions, we as-
sessed pharmaceutical cost groups (PCGs), which is the
most reliable proxy available in Swiss ambulatory health-
care claims data, and which is based on specific medication
classes (each medication class is defined based on the ATC
classification system) [16]. Other characteristics were mor-
tality (died in a given year), number of GPs caring for
the patient, number of GP consultations per year, num-
ber of specialists caring for the patient, number of special-
ist consultations per year, number and length of in-hospi-
tal stays (including emergency admissions), number of GP
telephone consultations per year, in- and outpatient costs,
and stay in a nursing home as a proxy for frailty.
Ethics approval and consent to participate
According to the national ethical and legal regulation,
ethics approval was not needed. Permission to access the
study data was provided by the Helsana Group. Since data
were anonymised, no consent of patients was required.
Statistical analysis
First, we calculated descriptive statistics for the total study
population (age, sex) and for the subgroups of interest (i.e.,
age 80 years or older, living in a nursing home), com-
paring patients with at least one home visit in the en-
tire observation period (2014–2018) to patients receiving
none. Extrapolated absolute numbers as well as weight-
ed means and standard deviations (SDs) were calculated.
The weighted mean of age, and its corresponding weight-
ing factor, corresponds to the median age in the given years
of observation per patient.
Second, to examine the time trend in GP home visits, we
compared the number of patients receiving at least one GP
home visit with the number of all patients in the extrapo-
lated study population, and thereof we calculated the rate
(in percentage). Additionally, multiple logistic regression
models were used to statistically test for changes in the
likelihood of GP home visits over time. The model includ-
ed getting at least one GP home visit per year per patient
as the dependent variable and time (5 years of observation)
as the independent variable, additionally controlled for the
composition of the study population using age and sex as
covariates. With a yearly cross-sectional design, some pa-
tients are observed over multiple years, resulting in non-in-
dependent observations over the course of time. However,
since taking into account the clustering of patients would
result in model outputs identical to the non-adjusted logis-
tic regression, the latter approach was used.
Third, we investigated the association between GP home
visits and the level of healthcare utilisation for the most re-
cent year, 2018. We performed separate multiple logistic
regression models with a binary indicator of having at least
one GP home visit in 2018 as the response variable, and the
multiple dimensions of level of health care and morbidity
as independent variables. Because of the problem of mul-
ticollinearity, each of the independent variables of interest
were tested in a separate logistic regression model, addi-
tionally controlled for age and sex.
Since age and sex were used as covariates to control for the
demography of the study population, the effects are not ex-
plicitly shown in the result tables of the regression models.
Extrapolation
We extrapolated the given results to the entire Swiss pop-
ulation to reduce potentially small differences between the
study and Swiss population regarding the distribution of
age, sex, and region of residence.
We used the following standard procedure for extrapola-
tion: For each observation, a weighting factor was deter-
mined based on stratification by year, canton, sex and age.
The weighting factors represent the inverse of the sam-
pling probabilities with the number of the entire Swiss
population (census data) relative to the number of indi-
viduals insured with Helsana in a given stratum (NSwitzer-
land, i / NHelsana, j ; i = stratum). The strata consisting of the
combination of year, canton, sex and age, and the corre-
sponding numbers of the Helsana collective and the entire
Swiss population were based on risk equalisation statistics
[17]. The corresponding weighting factors were used to
calculate weighted sums (extrapolated absolute numbers),
means and SDs representing the estimates of the extrapo-
lated population.
All the analyses described above were repeated for patients
aged 80 years or older and for patients with at least one
stay in a nursing home in a given year. P-values equal to or
below 0.05 were considered as statistically significant. We
used the statistical software R (version 4.0.2) for the analy-
ses [18].
Analyses based on raw (not extrapolated) data are provided
in the appendix (supplementary tables S3, S4 and S5).
Results
Population and GP home visit rates
Between 2014 and 2018, the total extrapolated population
resulted in 2,095,102 patients aged 65 years or older (raw
study population [Helsana] ≥65: Nraw = 339,301). During
the entire observation period, 413,234 (19.7%) (Nraw =
73,576) patients received at least one GP home visit, of
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whom 63.7% were women (table 1). The GP home visit
rates per year were between 9.3% and 10.7% (fig. 1a).
The subgroup including patients aged 80 years or older
(Nextrapolated = 695,136; Nraw = 127,237) showed an overall
proportion of 42.6% patients with at least one GP home
visit between 2014 and 2018 (table 1), and GP home visit
rates per year were between 23.1% and 26.1% (fig. 1b). In
the subgroup of patients with at least one stay in a nurs-
ing home in the given period (Nextrapolated = 305,982; Nraw
= 56,155), 77.7% had at least one GP home visit (table 1),
and GP home visit rates per year were between 65.8% and
68.7% (fig. 1c).
Time trend
Between 2014 and 2018 the number of patients receiving
at least one GP home visit per year declined by 6.3%,
from 160,792 to 150,717, whereas the total number of pa-
tients aged ≥65 years increased (by 7%, from 1,505,379 to
1,618,958) (fig. 1a). This is equivalent to a decrease in the
GP home visit rate from 10.7% to 9.3% (fig. 1a), which is
a relative decrease of 13.1% between 2014 and 2018, or
3.3% per year. (p <0.001, controlled for age and sex, sup-
plementary table S1a in the Appendix).
The decreasing trend of the GP home visit rate between
2014 and 2018 remained significant for the subgroups of
patients ≥80 years (p <0.001, controlled for age and sex)
(fig. 1b, table S1b) and patients living in a nursing home (p
<0.001, controlled for age and sex) (fig. 1c, table S1c). For
absolute extrapolated numbers, see table S2.
Patient characteristics associated with GP home visits
The numbers of patients with GP home visits were gener-
ally higher among women and older patients (tables 1–3).
In the year 2018, patients with GP home visits were more
often hospitalised (odd ratio [OR] 1.87, 95% confidence
interval [CI] 1.85–1.89), had a higher probability of living
in a nursing home (OR 19.7, 95% CI 19.0–20.4), a higher
number of GPs (OR 2.67, 95% CI 2.62–2.72) and a lower
number of specialists as care providers (OR 0.85, 95% CI
0.84–0.86), and had a higher mortality rate (OR 6.93, 95%
CI 6.12–7.26), as compared with patients with no GP home
visits (tables 2 and 3). Very similar effects were found in
the subgroup of patients aged 80 years or older. In the sub-
group of patients living in a nursing home, the effect of
hospitalisations becomes less relevant (OR 1.05, 95% CI
1.04–1.07) (tables 2 and 3).
Table 1: Descriptive statistics of the extrapolated population for patients without vs with at least one GP home visit during the entire observation period (2014–2018), for the en-
tire population (≥65 years) as well as for the two subgroups including patients ≥80years and patients living in a nursing home.
Without GP home visit With at least one GP home visit
(a) All patients ≥65 years
(N = 2,095,102)
n (overall) 1,681,868 (80.3%) 413,234 (19.7%)
n women (%) 886,105 (52.7%) 263,326 (63.7%)
Age, mean ± SD) 73.6 ± 6.8 82.5 ± 8.0
(b) Subgroup ≥80 years
(N = 695,136)
n (≥80 years) 398,921 (57.4%) 296,215 (42.6%)
n women (%) 225,854 (56.6%) 198,835 (67.1%)
Age, mean ± SD) 84.3 ± 3.8 87.2 ± 4.8
(c) Subgroup with a stay in a nursing home
(N = 305,982)
n (nursing home) 68,235 (22.3%) 237,747 (77.7%)
n women (%) 43,185 (63.3%) 160,576 (67.5%)
Age, mean ± SD) 82.0 ± 8.0 84.9 ± 7.4
Absolute numbers represent extrapolations to whole Switzerland. Age is given as the weighted mean ± standard deviation (SD).
Figure 1: The proportion (%) of patients with at least one GP home visit relative to the total number of patients per year. (a) Overall patients
(aged ≥65 years). (b) Subgroup including only patients aged ≥80 years. (c) Subgroup including only patients with a stay at a nursing home in
the same year. A significant decrease in GP home visit rates was been observed in all patient groups (p <0.001, controlled for age and sex)
(table S1).
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Discussion
During a given year in the study period from 2014 to 2018,
one out of ten patients aged 65 years or older received a
home visit by a GP. This rate doubled among patients aged
80 years or older and reached over 65% in patients living
in a nursing home. Between 2014 and 2018, the GP home
visit rate declined from 10.7% to 9.3%, corresponding to
an average GP home visit rate decline of 3.3% per year
for this study period (relative reduction). Our data show
that patients with GP home visits have more comorbidities,
more and longer hospital stays, are more likely to live in
a nursing home, have higher costs and have a higher mor-
tality. This reflects a higher burden of disease and frailty,
which may result in a higher demand by these patients for
home-based medical care.
Compared with the literature, the decline in GP home visits
during our study period seems slightly smaller than in pre-
vious years. For example, a Dutch study reported a rela-
tive GP home visit rate reduction of 3.5% per year between
1987 and 2001 [3], and an Australian study reported a rel-
ative GP home visit rate reduction of 5.1% per year for the
years 1997 to 2007 [19]. In Switzerland, the mean num-
ber of GP home visits per week decreased from 7.7 (me-
dian 5.0) in 1993 to 3.2 (median 2.0) in 2012, translating
into a relative reduction of 4.5% per year [14]. Another
Swiss study, restricted to the area of the canton of Vaud,
reported an annual decrease of home visits per GP by 4%
during the time period from 2006 to 2015 [15]. However,
comparisons should be made with caution as study pop-
ulations differ in age, living situation and healthcare sys-
tems. As potential reasons for the decline in GP home visit
rates, qualitative studies have identified barriers such time
constraints, inadequate remuneration, lack of equipment,
and concerns about safety and perceptions of a risk of vio-
lence [1, 12]. Recent organisational development in patient
care, such as improved transport facilities (to overcome
impaired mobility) or telemedical advice, may be further
reasons for the decline.
As to be expected, the strongest indicator for the provision
of a GP home visit in our study was the living situation:
staying in a nursing home translated to an almost 20-fold
increase of the probability for a GP home visit compared
with community-dwelling individuals. This is in line with
a recent Swiss study including almost 230,000 individuals
aged 65 or older, where patients with more GP home visits
were significantly more often dependent on home care
nursing, and had more and longer hospitalisations [10].
Another strong effect on GP home visits was co-morbidity,
with an increase by one third for every additional PCG.
This is in line with the literature: Moth et al. reported sig-
nificantly higher home visit rates if patients had three or
more chronic conditions as compared with none [9]. Sim-
ilarly, in the Swiss study mentioned above, the home visit
rates among patients with two or more chronic conditions
were significantly higher than in patients with only one or
no chronic condition [10]. A Danish study among hospi-
talised patients with chronic obstructive pulmonary disease
found that patients with a Charlson comorbidity index of
1 or higher than 1 versus 0 had ORs of 1.63 and 2.02, re-
spectively, for having a GP home visit in the previous year
[20].
GP home visit rates are clearly higher in older patients, es-
pecially among those aged 80 years or older [3, 20]. Re-
garding sex, other studies reported an association with fe-
male sex [5, 20], which may partially be explained by the
higher age of female patients as compared with men.
Finally, our results showed a positive association between
the number of different GPs and GP home visits, with the
Table 2: Patient characteristics with regard to health conditions and healthcare utilisation (year 2018) for (a) overall patients in the Swiss population (extrapolated) (aged ≥65
years); (b) subgroup of patients ≥80 years; (c) subgroup of patients living in a nursing home in the same year, 2018.
2018 (a) All patients
(N = 1,618,958) (extrapolated)
(b) Subgroup ≥80years
(N = 480,109) (extrapolated)
(c) Subgroup living in a nursing home
(N = 135,559) (extrapolated)
With GP home
visit
Without GP home visit With GP home visit Without GP home
visit
With GP home visit Without GP home
visit
No. patients (%) 150,717 (9.3%) 1,468,241 (90.7%) 111,115 (23.1%) 368,994 (76.9%) 89,181 (65.8%) 46,378 (34.2%)
% women 67.7% 54.2% 71.1% 59.1% 70.2% 67.0%
Age 84.4 74.8 88.3 84.9 86.2 84.0
Inpatient characteristics
Inpatient costs 13,927.5 2206.9 13,734.9 3424.2 19,056.1 17,057.8
Number of stays 1.8 0.4 1.8 0.6 2.3 2.3
Total length of stays (days) 158.2 9.5 172.6 23.7 258.0 217.1
% patients in nursing home 59.2% 3.2% 65.3% 9.1% 100% 100%
Outpatient characteristics
Outpatient costs 11,148.8 5977.7 9853.5 6813.2 8612.9 8854.2
No. of GPs 1.7 1.0 1.7 1.1 1.7 0.9
No. of specialists 1.4 2.2 1.3 2.1 1.0 1.3
No. of GP consultations 11.2 5.2 11.0 6.3 11.0 5.3
No. of specialist consultations 3.6 5.1 3.0 5.3 2.6 5.6
No. of GP telephone consultations 1.6 0.3 1.6 0.4 1.5 0.5
Other characteristics
Home nursing service costs 2674.1 326.4 2685.7 832.5 1372.8 1456.4
No. of PCGs 4.2 2.5 4.1 3.1 4.4 3.9
% patients died 21.3% 1.9% 23.0% 4.4% 25.6% 18.7%
PCG = pharmaceutical cost group If not stated otherwise, weighted mean values are given. Costs are presented in Swiss francs (CHF); 1 CHF is equivalent to EUR 0.93, GBP
0.84 or USD 1.12 (as of end 2020)
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strongest association in the nursing home subgroup. As an
explanation, we assume that frail patients at high need for
GP home visits require this service regardless of whether
their GP is available or not (e.g., out-of-hours situation,
vacancy). Furthermore, the number of different specialists
was negatively associated with GP home visits. Both find-
ings demonstrate that these vulnerable patients demand
more home-based care, and that the specialised provider of
this longitudinal medical care is the GP [1].
Regarding effectiveness, an older meta-analysis showed a
reduction of mortality and admission to institutional care
by planned home visits, but no effect for function, health
change and hospital admission, whereas other studies of
house call programmes reported a reduction of hospitalisa-
tion rates and emergency room visits [21, 22]. Another re-
cent systematic review found no evidence for a reduction
of hospital admission or other clinical events by primary
care-led home visits for acute medical emergencies [23].
Beyond clinical events, there are some beneficial effects
of GP home visits to mention: for example, visiting the
patient allows a discussion of options and shared decision
making regarding next steps in a trusted and comfortable
environment, thus encouraging better adherence of the pa-
tient [23, 24]. This may be particularly true for people who
have complex care needs, where the GP is gaining a better
knowledge of coping capacities of patients and caregivers
during the visit [23]. Another population at high need for
home-based care are patients requiring a palliative care,
where GPs provide visits in collaboration with specialised
Table 3: Multiple logistic regression analyses testing the effects of patient characteristics regarding health conditions and healthcare utilisation on the likelihood of receiving at
least one GP home visit for 2018 for (a) overall patients in the Swiss population (extrapolated) (aged ≥65 years); (b) subgroup of patients ≥80 years; (c) subgroup of patients liv-
ing in a nursing home in the same year, 2018.
Independent variable Odds ratio 95% CI p-value
(a) All patients (≥65 years)
Inpatient costs 1.0001 1.0001–1.0001 <0.001
Number of stays 1.8714 1.8526–1.8904 <0.001
Total length of stays 1.0093 1.0092–1.0095 <0.001
Stay in a nursing home 19.7114 19.0345–20.4136 <0.001
Outpatient costs 1.000031 1.00003–1.000032 <0.001
No. of GPs 2.6686 2.6221–2.7161 <0.001
No. of specialists 0.8481 0.841–0.8552 <0.001
No. of GP consultations 1.0942 1.0922–1.0961 <0.001
No. of specialist consultations 0.9647 0.9622–0.9671 <0.001
No. of GP telephone consultations 1.3894 1.3783–1.4005 <0.001
Home nursing service costs 1.0001 1.0001–1.0001 <0.001
No. of PCGs* 1.3673 1.3581–1.3766 <0.001
Died 6.9267 6.612–7.2568 <0.001
(b) Subgroup: age ≥80 years
Inpatient costs 1.0001 1.0001–1.0001 <0.001
Number of stays 1.8134 1.7899–1.8373 <0.001
Total length of stays 1.008 1.0078–1.0081 <0.001
Stay in a nursing home 13.9133 13.3759–14.4738 <0.001
Outpatient costs 1.00003 1.000029–1.000032 <0.001
No. of GPs 2.7766 2.713–2.8421 <0.001
No. of specialists 0.8125 0.8038–0.8213 <0.001
No. of GP consultations 1.0916 1.0891–1.0941 <0.001
No. of specialist consultations 0.9455 0.9423–0.9486 <0.001
No. of GP telephone consultations 1.4077 1.3923–1.4234 <0.001
Home nursing service costs 1.00007 1.00006–1.00007 <0.001
No. of PCGs† 1.3187 1.3075–1.33 <0.001
Died 5.0472 4.7928–5.3158 <0.001
(c) Subgroup: living in a nursing home
Inpatient costs 1.00002 1.000013–1.000018 <0.001
Number of stays 1.0526 1.0373–1.0682 <0.001
Total length of stays 1.0019 1.0017–1.0021 <0.001
Outpatient costs 1.000004 1.000002–1.000007 0.001
No. of GPs 4.0419 3.8609–4.2339 <0.001
No. of specialists 0.8945 0.879–0.9102 <0.001
No. of GP consultations 1.1224 1.1172–1.1277 <0.001
No. of specialist consultations 0.948 0.9443–0.9517 <0.001
No. of GP telephone consultations 1.3089 1.2838–1.3351 <0.001
Home nursing service costs 0.999999 0.999993–1.000005 0.822
No. of PCGs‡ 1.1429 1.1279–1.1582 <0.001
Died 1.4403 1.3498–1.5373 <0.001
CI = confidence interval; PCG = pharmaceutical cost group Each logistic regression is controlled for age and sex as covariates (effects not shown). The effects of age and sex
in each of the models (except from sex in the subgroup of people living in nursing homes with no significance) show statistical significance with a positive age effect and women
having a higher likelihood of GP home visits. Adjusted threshold of significance (Bonferroni): 0.05/38 = 0.001. * n = 264,222 instead of 266,867 due to missing values in number
of PCGs. † n = 87,965, instead of 90,116 due to missing values in number of PCGs. ‡ n = 22’922, instead of 25,565 due to missing values in number of PCGs.
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services. Many patients, especially older patients, consider
home visits to be essential for their well-being and for the
GP–patient relationship, and subsequently for better care
[2]. However, more research is needed to explore the ex-
pectations of patients and their benefits from GP home vis-
its, in order to evaluate if the high demand is mirroring a
real need of patients, beyond convenience.
In the light of the decline of GP home visits, we have to
think about potential solutions. The integration of other
health professionals into home-based medical care for old-
er, multimorbid patients seems justified [22]. For example,
nurses in advanced roles may successfully provide home
visits for chronically ill patients, at a similar care quality
as GPs [25], and may dedicate a substantial part of their
working time to this task [26, 27]. Additionally, organisa-
tional factors on a practice level and on the healthcare sys-
tem level (e.g., salary or gatekeeping systems) are associat-
ed with GP home visit rates and should be considered [13].
The debate is ongoing and deserves careful attention [28,
29]. More research data on these barriers and innovative
solutions are urgently needed to provide more insight for
informing political stakeholders.
Strengths and limitations
One strength of our study was the huge study population
covering one eighth of the Swiss population in a nation-
wide sample, which we assume to be representative for the
Swiss population according to previous studies [30, 31], al-
though this has not been proven yet. Another strength is
the up-to-date analysis of time trends in home visits over
a recent time period of 5 years. Lastly, our study is unique
in stratifying results according to vulnerable subgroups and
investigating patient determinants with a focus on health-
care utilisation, in order to investigate how rates and time
trends differ between subgroups and the entire study sam-
ple.
As a limitation, the observational design does not allow for
causality or clinical diagnosis. Therefore, we cannot ex-
plore decisional procedures and reasons for home visits,
nor further factors influencing healthcare utilisation such
as educational level, socioeconomic status, or social sup-
port of patients. Another limitation is the lack of informa-
tion about GPs’ characteristics (such as age, sex, educa-
tional level, working place), which hinders exploration of
associations between these characteristics and the provi-
sion of home care.
Availability of data and materials
On request, source data and materials are available from
the authors.
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Appendix: Supplementary tables
Table S1: Multiple logistic regression analyses testing for the effect of time for (a) all patients included in the study, (b) patients aged 80 or older, (c) patients living in a nursing
home.
Predictor Estimate SE p-value
(a) All patients (≥ 65 years)
(Intercept) −14.32553 0.03453 <0.001
Age 0.15261 0.00041 <0.001
Sex (f) 0.32211 0.00652 <0.001
Time (years) −0.05481 0.00216 <0.001
(b) Patients ≥80 years
(Intercept) −14.81275 0.07048 <0.001
Age 0.15777 0.00081 <0.001
Sex (f) 0.37908 0.00803 <0.001
Time (years) −0.05288 0.00260 <0.001
(c) Patients living in a nursing home
(Intercept) −2.12529 0.07041 <0.001
Age 0.03447 0.00082 <0.001
Sex (f) 0.04164 0.01363 0.022
Time (years) −0.03729 0.00430 <0.001
Table S2: The weighted total numbers of patients per year and the weighted number of patients with at least one GP home visit per year for (a) overall patients in the Swiss pop-
ulation (extrapolated) (aged ≥65 years); (b) subgroup of patients ≥80 years; (c) subgroup of patients living in a nursing home in the same year. A significant decrease in GP
home visit rates was observed in all patient groups (p <0.0001, controlled for age and sex) (table S1).
2014 2015 2016 2017 2018
(a) All patients (≥65 years)
Patients, total 1,,505,,379 1,539,800 1,562,664 1,591,730 1,618,958
Patients with GP
home visit
160,792 160,936 155,908 155,471 150,717
(b) Patients ≥80 years
Patients, total 444,247 455,990 462,145 470,753 480,109
Patients with GP
home visit
115,870 117,527 113,967 114,036 111,115
(c) Patients living in a nursing home
Patients, total 127,406 132,197 130,834 133,724 135,559
Patients with GP
home visit
87,534 90,330 88,860 90,131 89,181
Table S3: Descriptive statistics of the raw data (Helsana sample) for patients without vs with at least one GP home visit during the entire observation period (2014–2018), for the
entire population (≥65 years) as well as for the two subgroups including patients ≥80years and patients living in a nursing home.
Without GP home visit With at least one GP home visit
(a) All patients ≥65 years
(N = 339,301)
n (overall) 265,725 (78.32%) 73,576 (21.68%)
n women (%) 145,603 (54.8%) 48,784 (66.3%)
Age, mean ± SD 74.4 ± 6.9 83.1 ± 7.9
(b) Subgroup ≥80 years
(N = 127,237)
n (≥80 years) 71,818 (56.44%) 55,419 (43.56%)
n women (%) 42,330 (58.9%) 38,405 (69.3%)
Age, mean ± SD 84.4 ± 3.8 87.4 ± 4.8
(c) Subgroup with a stay in a nursing home
(N = 56,155)
n (nursing home) 12,396 (22.07%) 43,759 (77.93%)
n women (%) 8181 (66%) 30,598 (69.9%)
Age, mean ± SD 82.2 ± 7.7 85.3 ± 7.2
Age is given as the weighted mean ± standard deviation (SD).
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Table S4: Patient characteristics with regard to health conditions and healthcare utilization (year 2018) for (a) overall patients in the Helsana sample (aged ≥65 years); (b) sub-
group of patients ≥80 years; (c) subgroup of patients living in a nursing home in the same year, 2018
2018 (a) All patients
(N = 266,867) (raw)
(b) Subgroup ≥80 years
(N = 90,116) (raw)
(c) Subgroup living in a nursing home
(N = 25,565) (raw)
With GP home vis-
it








No. patients (%) 27,602 (10.34%) 23,9265 (89.66%) 21,380 (23.72%) 68,736 (76.28%) 16,818 (65.79%) 8747 (34.21%)
% women 70.25% 56.53% 73.19% 61.49% 72.65% 69.68%
Age 85.2 75.5 88.5 85.0 86.8 84.7
Inpatient characteristics
Inpatient costs 13,625.9 2260.0 13,444.4 3424.9 18,423.5 16,543.8
Number of stays 1.8 0.4 1.8 0.6 2.3 2.2
Total length of stays (days) 161.5 10.7 174.0 24.8 256.8 218.5
% patients in nursing home 60.93% 3.66% 66.21% 9.64% 100% 100%
Outpatient characteristics
Outpatient costs 10,762.3 5976.8 9680.0 6781.1 8358.0 8562.9
No. of GPs 1.7 1.0 1.7 1.1 1.7 0.9
No. of specialists 1.4 2.2 1.2 2.1 1.0 1.3
No. of GP consultations 11.3 5.3 11.2 6.3 11.1 5.1
No. of specialist consultations 3.5 5.1 3.0 5.3 2.6 6.1
No. of GP telephone consultations 1.6 0.3 1.6 0.4 1.5 0.5
Other characteristics
Home nursing service costs 2636.8 351.9 2662.9 841.9 1358.6 1412.7
No. of PCGs 4.2 2.6 4.1 3.1 4.3 3.8
% patients died 21.62% 2.04% 23.03% 4.44% 25.8% 18.54%
PCG = pharmaceutical cost group
If not stated otherwise, weighted mean values are given. Costs are presented in Swiss francs (CHF); 1 CHF is equivalent to EUR 0.93, GBP 0.84 or USD 1.12 (as of end 2020)
Table S5: The total numbers of patients per year and the number of patients with at least one GP home visit per year, in the Helsana sample for (a) overall patients (aged ≥65
years); (b) subgroup of patients ≥80 years; (c) subgroup of patients living in a nursing home in the same year A significant decrease in GP home visit rates was been observed
in all patient groups (p <0.0001, controlled for age and sex).
2014 2015 2016 2017 2018
(a) All patients (≥65 years)
Patients, total 265,828 268,368 266,693 264,617 266,867
Patients with GP home visit 30,561 30,510 29,198 28,635 27,602
(b) Patients ≥80 years
Patients, total 85,986 87,915 88,399 88,946 90,116
Patients with GP home visit 22,828 23,165 22,327 22,107 21,380
(c) Patients living in a nursing home
Patients, total 24,594 25,448 24,997 25,295 25,565
Patients with GP home visit 16,931 17,474 16,992 17,059 16,818
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